Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 701–800 of 1,012
Therapeutic implications of renal anionic drug transporters
Masereeuw, R., & Rüssel, F. G. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.007 · Cited by 94
“ABCC1/MRP1 was originally identified in a lung cancer cell line (Cole et al., 1992).”
BackgroundKEPPLER, D. O. R., König, J., & Büchler, M. W. (1997) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(96)00013-1 · Cited by 89
Naruse, I., Ohmori, T., Ao, Y., Fukumoto, H., Kuroki, T., Mori, M., Saijo, N., & Nishio, K. (2001) · International Journal of Cancer · doi:10.1002/ijc.10173 · Cited by 89
Chen, D., Song, M., Mohamad, O., & Yu, S. P. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-716 · Cited by 96
“One way in which cancer cells can achieve resistance to anti-cancer drugs is by up-regulating the ATP-binding cassette transporter proteins which are responsible for the efflux of anti-cancer molecules from the intracellular compartment [8].”
BackgroundPramanik, D., Campbell, N. R., Das, S., Gupta, S., Chenna, V., Bisht, S., Sysa‐Shah, P., Bedja, D., Karikari, C. A., Steenbergen, C., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.543 · Cited by 96
“For instance, resistance of metastatic tumors to the anthracycline doxorubicin (DOX) has been linked to overexpression of ABC transporters ABCB1 (MDR1/Pglycoprotein) [7], ABCC1 (MRP1) [8], ABCC2 (MRP2) [9, 10] and ABCG2 (MXR, BRCP) [11-13].”
Paul, S., Breuninger, L. M., Tew, K. D., Shen, H., & Kruh, G. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6929 · Cited by 89
RetractedBeck, J. F., Handgretinger, R., Dopfer, R. E., Klingebiel, T., NIETHAMMER, D., & Gekeler, V. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb03312.x · Cited by 93
The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice.
Johnson, D. R., Finch, R. A., Lin, Z., Zeiss, C. J., & Sartorelli, A. C. (2001) · PubMed · Cited by 102
Overcoming drug resistance by regulating nuclear receptors
Chen, T. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.008 · Cited by 88
Ramaen, O., Leulliot, N., Sizun, C., Ulryck, N., Pamlard, O., Lallemand, J., TILBEURGH, H. V., & Jacquet, E. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.04.005 · Cited by 116
Wong, I. L. K., Chan, K., Tsang, K. H., Lam, C. Y., Zhao, Y., Chan, T. H., & Chow, L. M. C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900194w · Cited by 102
Valdameri, G., Genoux‐Bastide, E., Pérès, B., Gauthier, C., Guitton, J., Terreux, R., Winnischofer, S. M. B., Rocha, M. E. M., Boumendjel, A., & Pietro, A. D. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201404w · Cited by 102
Sugimoto, Y., Tsukahara, S., Ishikawa, E., & Mitsuhashi, J. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00081.x · Cited by 95
Yang, H. H., Ma, M. H., Vescio, R. A., & Berenson, J. R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.001 · Cited by 96
Zattoni, I. F., Delabio, L. C., Dutra, J. D. P., Kita, D. H., Scheiffer, G., Hembecker, M., Pereira, G. D. S., Moure, V. R., & Valdameri, G. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114346 · Cited by 95
Multidrug resistance protein 4 (MRP4/ABCC4) mediates efflux of bimane-glutathione
Bai, J., Lai, L., Yeo, H. C., Goh, B. C., & Tan, T. M. C. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00236-x · Cited by 98
Larkin, A., O’Driscoll, L., Kennedy, S., Purcell, R. V., Moran, E., Crown, J. P., Parkinson, M. D., & CLYNES, M. M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20369 · Cited by 87
The emerging role of nuclear factor kappa B in renal cell carcinoma
Morais, C., Gobe, G. C., Johnson, D. W., & Healy, H. G. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.003 · Cited by 98
“The observation that MDR can be present in tumors and cell lines that do not express P-gp led to the discovery of a second type of drug pump, called the multi-drug resistance-associated protein (MRP) (Cole et al., 1992).”
BackgroundFunctional Expression of the Multidrug Resistance Protein 1 in Microglia
Dallas, S., Zhu, X., Baruchel, S., Schlichter, L. C., & Bendayan, R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.054304 · Cited by 97
Hinoshita, E., Taguchi, K., Inokuchi, A., Uchiumi, T., Kinukawa, N., Shimada, M., Tsuneyoshi, M., Sugimachi, K., & Kuwano, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00216-1 · Cited by 87
Large Granular Lymphocyte Leukemia
Lamy, T., & Loughran, T. P. (1998) · Cancer Control · doi:10.1177/107327489800500103 · Cited by 87
Zhang, D.-W., Cole, S. P. C., & Deeley, R. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010008200 · Cited by 87
Self-citationAminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion
Ishii, K., Usui, S., Sugimura, Y., Yoshida, S., Hioki, T., Tatematsu, M., Yamamoto, H., & Hirano, K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999<::aid-ijc1178>3.0.co;2-6 · Cited by 128
A Yeast ATP-binding Cassette-type Protein Mediating ATP-dependent Bile Acid Transport
Ortiz, D. F., Pierre, M. V. S., Abdulmessih, A., & Arias, I. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15358 · Cited by 86
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma
Manohar, C. F., Bray, J. A., Salwen, H. R., Madafiglio, J., Cheng, A. J., Flemming, C. L., Marshall, G. M., Norris, M. D., Haber, M., & Cohn, S. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207151 · Cited by 88
“The multidrug resistance-associated protein (MRP1) gene encodes a 190 kDa membrane-bound glycoprotein that belongs to the superfamily of ATP-binding cassette (ABC) transmembrane transporters (Cole et al., 1992).”
BackgroundConrad, S., Kauffmann, H.-M., Ito, K., Deeley, R. G., Cole, S. P. C., & Schrenk, D. (2001) · Journal of Human Genetics · doi:10.1007/s100380170017 · Cited by 87
“It encodes a 190-kDa polytopic transmembrane protein comprising 1531 amino acids and belongs to subfamily C of the superfamily of ATP-binding cassette (ABC)-transporters (Cole et al. 1992; Hipfner et al. 1999a; Hopper et al. 2001; Kuwano et al. 1999).”
BackgroundSelf-citationSmall cell lung cancer: Etiology, biology, clinical features, staging, and treatment
Cook, R. F., Miller, Y. E., & Bunn, P. A. (1993) · Current Problems in Cancer · doi:10.1016/0147-0272(93)90010-y · Cited by 89
Melanoma stem cells: not rare, but well done
Girouard, S. D., & Murphy, G. F. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.50 · Cited by 103
New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer
van Hattum, A. H., Pinedo, H. M., Schlüper, H. M. M., Hausheer, F. H., & Boven, E. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001015)88:2<260::aid-ijc18>3.0.co;2-q · Cited by 86
Role of Cys‐603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2
Kage, K., Fujita, T., & Sugimoto, Y. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00126.x · Cited by 103
Guo, A., Marinaro, W., Hu, P., & Sinko, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.457 · Cited by 86
“However, there was no significant difference in etoposide efflux between the resistant cell line KB/7D and the sensitive cell line KB. Cole et al. (1992) also reported that H69/AR cells in which the MRP1 gene was identified were more resistant to etoposide than parental H69 cells; however, there…”
BackgroundRLIP76, a Novel Transporter Catalyzing ATP-Dependent Efflux of Xenobiotics
Awasthi, S., Sharma, R., Singhal, S. S., Zimniak, P., & Awasthi, Y. C. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1300 · Cited by 86
“…2001; i Awasthi et al. 2002; j Gottesman and Pastan, 1993; k Dean et al. 2001; l Higgins, 1992; m Thiebaut et al. 1987; n Ambudkar et al. 1999; o Cole et al. 1992; p Bakos et al. 1996; q Flens et al. 1996; r Leslie et al. 2001. at A SPE T Journals on A ugust 8, 2017 dm d.aspetjournals.org D ow…”
BackgroundInfluentialMolecular and functional MDR1‐Pgp and MRPs expression in human glioblastoma multiforme cell lines
Declèves, X., Fajac, A., Lehmann‐Che, J., Tardy, M., Mercier, C., Hurbain, I., Laplanche, J., Bernaudin, J., & Scherrmann, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10135 · Cited by 96
Hasegawa, S., Taniguchi, K., Yokomizo, A., Kuwano, T., Ono, M., Mori, T., Hori, S., Kohno, K., & Kuwano, M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580619 · Cited by 95
Uchiumi, T., Hinoshita, E., Haga, S., Nakamura, T., Tanaka, T., Toh, S., Furukawa, M., Kawabe, T., Wada, M., Kagotani, K., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9546 · Cited by 86
Lin, Y.-T., Huang, Y.-W., Liou, R.-S., Chang, Y.-C., & Yang, T. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku317 · Cited by 94
Klugbauer, N., & Hofmann, F. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00700-4 · Cited by 85
Garg, T., Bhandari, S., Rath, G., & Goyal, A. K. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1029930 · Cited by 89
“PEG-conjugated immunoliposomes were synthesized using thiolated mAb and a bifunctional 2000-Da PEG (PEG 2000) that contains a lipid at one end and a maleimide at the other end [209].”
MethodAnnereau, J., Szakács, G., Tucker, C. J., Arciello, A., CARDARELLI, C. O., Collins, J., Grissom, S. F., Zeebèrg, B. R., Reinhold, W. C., Weinstein, J. N., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.005009 · Cited by 91
“RCO.1 presents a unique profile of multidrug resistance with a selective resistance to camptothecin analogs NB-506 (an inhibitor of topoisomerase I) and cisplatin, whereas being sensitive to drugs known to be exported by ABCB1-MDR1 or ABCC1-MRP1 (Chatterjee et al., 2001).”
BackgroundInfluentialDey, S., Gunda, S., & Mitra, A. K. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069583 · Cited by 85
“Multidrug resistance to absorption of drugs is mainly due to three proteins, P-glycoprotein (P-gp), lung resistance-related protein, and multidrug resistance associated protein-1 (Cole et al., 1992; Scheper et al., 1993).”
BackgroundDhar, S., Nygren, P., Csóka, K., Botling, J., Nilsson, K., & Larsson, R. L. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.453 · Cited by 83
Regulation of Transcription Factor Pdr1p Function by an Hsp70 Protein in Saccharomyces cerevisiae
Hallstrom, T. C., Katzmann, D. J., Torres, R. J., Sharp, W. J., & Moye-Rowley, W. S. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1147 · Cited by 84
Cantz, T., Nies, A. T., Brom, M., Hofmann, A. F., & KEPPLER, D. O. R. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.4.g522 · Cited by 85
“The first cloned member of the multidrug resistance protein family was MRP1, which was cloned from a small lung cancer cell line (8).”
BackgroundMethodExpression of the Apical Conjugate Export Pump, Mrp2, in the Polarized Hepatoma Cell Line, Wif–B
Nies, A. T., Cantz, T., Brom, M., Leier, I., & KEPPLER, D. O. R. (1998) · Hepatology · doi:10.1002/hep.510280523 · Cited by 84
Perkins, M. E., Riojas, Y. A., Wu, T. W., & Blancq, S. M. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5734 · Cited by 83
Specific Inhibitors of the Breast Cancer Resistance Protein (BCRP)
Pick, A., Klinkhammer, W., & Wiese, M. (2010) · ChemMedChem · doi:10.1002/cmdc.201000216 · Cited by 102
Interaction between Metabolism and Transport of Benzo[a]pyrene and Its Metabolites in Enterocytes
Buesen, R., Mock, M., Seidel, A., Jacob, J., & Lampen, A. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9484 · Cited by 83
Chang, X.-B. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9041-7 · Cited by 97
Rickardson, L., Fryknäs, M., Dhar, S., Lövborg, H., Gullbo, J., Rydåker, M., Nygren, P., Gustafsson, M. G., Larsson, R., & Isaksson, A. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602699 · Cited by 82
“H69AR showed an increased expression of MRPl/ABCCl compared to all other cell lines, which is consistent with previous results, further supporting the validity of the array measurements (Cole et al, 1992).”
MethodResultJanuchowski, R., Sterzyńska, K., Zaorska, K., Sosińska, P., Klejewski, A., Brązert, M., Nowicki, M. O., & Zabel, M. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0278-z · Cited by 83
“Other important ABC transporters implicated in MDR of cancers include MRP1 and MRP2 (MDR1-related protein 1 and MDR-related protein 2) encoded by ABCC1 and ABCC2 genes, respectively [3, 13, 14].”
BackgroundRLIP76 Transports Vinorelbine and Mediates Drug Resistance in Non–Small Cell Lung Cancer
Stuckler, D., Singhal, J., Singhal, S. S., Yadav, S., Awasthi, Y. C., & Awasthi, S. (2005) · Cancer Research · doi:10.1158/0008-5472.991.65.3 · Cited by 83
“The expression of MDR1 gene product, Pgp, and MRP-1 are correlated with multidrug resistance associated with vinorelbine (14–16), and Vinca alkaloids are good substrates for these transporters (17, 18 ).”
BackgroundDevelopment of Multidrug-Resistance Convertors: Sense or Nonsense?
van Zuylen, L., Nooter, K., Sparreboom, A., & Verweij, J. (2000) · Investigational New Drugs · doi:10.1023/a:1006487003814 · Cited by 83
ABC transporters in Leishmania and their role in drug resistance
Ouellette, M., Légaré, D., Haimeur, A., Grondin, K., Roy, G., Brochu, C., & Papadopoulou, B. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80213-6 · Cited by 83
Gao, M., Yamazaki, M., Loe, D. W., Westlake, C. J., Grant, C. E., Cole, S. P. C., & Deeley, R. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10733 · Cited by 94
Self-citationEpithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
Jiang, Z., Sun, Y., Wang, S., & Ruan, J. (2017) · Journal of Cancer · doi:10.7150/jca.19079 · Cited by 94
“MRP has 13 members with sizes range from 1325 to 1545 amino acids, which is encoded by the ABCC gene family [15, 16].”
BackgroundBiophysical Aspects of P-Glycoprotein-Mediated Multidrug Resistance
Wadkins, R. M., & Roepe, P. D. (1997) · International review of cytology · doi:10.1016/s0074-7696(08)62587-5 · Cited by 91
Ryu, S., Kawabe, T., Nada, S., & Yamaguchi, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005149200 · Cited by 82
Drug-stimulated ATPase activity of the human P-glycoprotein
Scarborough, G. A. (1995) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf02110329 · Cited by 82
Pułaski, Ł., Jedlitschky, G., Leier, I., Buchholz, U., & KEPPLER, D. O. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00644.x · Cited by 91
The Role of Drug Efflux Pumps in Acute Myeloid Leukemia
van der Kolk, D. M., de Vries, E. G. E., Müller, M. M., & Vellenga, E. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290016773 · Cited by 90
“This led to the discovery of another MDR associated ABC transporter, MRP [114], nowadays called MRP1, since other MRPs have been identified.”
BackgroundYi, J., Gao, F., Shi, G., Li, H., Wang, Z., Shi, X., & Tang, X. (2002) · APOPTOSIS · doi:10.1023/a:1015331229263 · Cited by 82
Chen, W. S., Luker, K. E., Dahlheimer, J. L., Pica, C. M., Luker, G. D., & Piwnica-Worms, D. R. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00341-5 · Cited by 82
Slapak, C., Mizunuma, N., & Kufe, D. W. (1994) · Blood · doi:10.1182/blood.v84.9.3113.3113 · Cited by 82
The role of copper in drug-resistant murine and human tumors
Majumder, S., Chatterjee, S., Pal, S., Biswas, J. K., Efferth, T., & Choudhuri, S. K. (2008) · BioMetals · doi:10.1007/s10534-008-9174-3 · Cited by 88
Extrahepatic metabolism at the body's internal–external interfaces
Gundert‐Remy, U., Bernauer, U., Blömeke, B., Döring, B., Fabian, E. J., Goebel, C., Hessel‐Pras, S., Jäckh, C., Lampen, A., Oesch, F., et al. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.900565 · Cited by 95
“The prototypes of xenobiotic efflux carriers are P-gp (gene code ABCB1/MDR1), where P stands for permeability (Chen et al., 1986; Juliano & Ling, 1976), and MRP1 (gene code ABCC1; Cole et al., 1992).”
BackgroundHeinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961115)68:4<428::aid-ijc5>3.0.co;2-2 · Cited by 70
Létourneau, I. J., Deeley, R. G., & Cole, S. P. C. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000173484.51807.48 · Cited by 92
Self-citationCheepala, S., Hulot, J., Morgan, J. A., Sassi, Y., Zhang, W., Naren, A. P., & Schuetz, J. D. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134609 · Cited by 89
“In 1992, Cole, Deeley, and colleagues (64) cloned the multidrug resistance-associated protein gene, now known as ABCC1 or MRP1.”
BackgroundZheng, L. H., Bao, Y. L., Wu, Y., Yu, C., Meng, X., & Li, Y. X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.029 · Cited by 81
The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential
van Zanden, J. J., van der Woude, H., Vaessen, J., Usta, M., Wortelboer, H. M., Cnubben, N. H. P., & Rietjens, I. M. C. M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.002 · Cited by 90
Mechanism of action of P-glycoprotein in relation to passive membrane permeation.
Eytan, G., & Kuchel, P. (1999) · International Review of Cytology · doi:10.1016/s0074-7696(08)62148-8 · Cited by 88
Chen, K. G., Durán, G. E., Steger, K. A., Lacayo, N. J., Jaffrézou, J., Dumontet, C., & Sikic, B. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5974 · Cited by 81
Luker, G. D., & Piwnica-Worms, D. (2001) · Academic Radiology · doi:10.1016/s1076-6332(03)80738-9 · Cited by 81
Hipfner, D. R., Mao, Q., Qiu, W., Leslie, E. M., Gao, M., Deeley, R. G., & Cole, S. P. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15420 · Cited by 81
Self-citationGrant, C. E., Kurz, E. U., Cole, S. P. C., & Deeley, R. G. (1997) · Genomics · doi:10.1006/geno.1997.4950 · Cited by 92
Self-citationShustik, C., Dalton, W. S., & Gros, P. (1995) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)00040-a · Cited by 99
Bruckmueller, H., & Cascorbi, I. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1876661 · Cited by 93
“capacity to confer multidrug resistance (MDR) in a lung cancer cell line that was selected for resistance to doxorubicin [260].”
BackgroundMuñoz‐Martínez, F., Lu, P., Cortés-Selva, F., Pérez-Victoria, J. M., Jiménez, I. A., Ravelo, Á. G., Sharom, F. J., Gamarro, F., & Castanys, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1005 · Cited by 84
Mechanism Targeted Discovery of Antitumor Marine Natural Products
Nagle, D. G., Zhou, Y., Mora, F. D., Mohammed, K. A., & Kim, Y.-P. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043364991 · Cited by 90
Miwa, M., Tsukahara, S., Ishikawa, E., Asada, S., Imai, Y., & Sugimoto, Y. (2003) · International Journal of Cancer · doi:10.1002/ijc.11484 · Cited by 91
ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
Ohishi, Y., Oda, Y., Uchiumi, T., Kobayashi, H., Hirakawa, T., Miyamoto, S., Kinukawa, N., Nakano, H., Kuwano, M., & Tsuneyoshi, M. (2002) · PubMed · Cited by 80
Wang, S., Folkes, A. J., Chuckowree, I., Cockcroft, X. F., Sohal, S., Miller, W., Milton, J., Wren, S. P., Vicker, N., Depledge, P., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm031011g · Cited by 80
Membrane transport proteins associated with drug resistance expressed in human melanoma.
Schadendorf, D., Makki, A., Stahr, C., van Dyck, A., Wanner, R. M., Scheffer, G. L., Flens, M. J., Scheper, R. J., & Henz, B. M. (1995) · Europe PMC (PubMed Central) · Cited by 80
Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
Luker, K. E., Pica, C. M., Schreiber, R. D., & Piwnica-Worms, D. R. (2001) · PubMed · Cited by 89
Genotyping the risk of anthracycline-induced cardiotoxicity
Deng, S., & Wojnowski, L. (2007) · Cardiovascular Toxicology · doi:10.1007/s12012-007-0024-2 · Cited by 79
“Both genes belong to subfamily C of ATP-binding cassette (ABC) transporters, act as cellular efflux pumps for overlapping spectra of endo- and exogenous substrates, and increase resistance to anthracyclines [28, 29].”
BackgroundEfflux Protein Expression in Human Retinal Pigment Epithelium Cell Lines
Mannermaa, E., Vellonen, K., Ryhänen, T., Kokkonen, K., Ranta, V., Kaarniranta, K., & Urtti, A. O. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9890-6 · Cited by 79
“DNA standard curves derived from expression plasmids of MDR1 (26), MRP1 (27), MRP2 (28), MRP3 (29), MRP4 (30), MRP5 (31), MRP6 (32) and BCRP (33).”
BackgroundDirect Measurement of Sizes and Dynamics of Single Living Membrane Transporters Using Nanooptics
Xu, X. N., Chen, J., Jeffers, R. B., & Kyriacou, S. V. (2002) · Nano Letters · doi:10.1021/nl015682i · Cited by 79
Combined effects of GSTP1 and MRP1 in melanoma drug resistance
Depeille, P., Cuq, P., Passagne, I., Evrard, A., & Vian, L. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602681 · Cited by 82
“Multidrug resistance protein 1 and MRP2 belong to the nine members family of ABC transporters, discovered by Cole et al (1992), that are responsible for the active transport across biological membrane of structurally diverse lipophilic anions (Borst et al, 1999; Kruh and Belinsky, 2003).”
BackgroundFrelet‐Barrand, A., Kolukisaoglu, H. Ü., Plaza, S., Rüffer, M., Azevedo, L., Hörtensteiner, S., Marinova, K., Weder, B., Schulz, B., & Klein, M. (2008) · Plant and Cell Physiology · doi:10.1093/pcp/pcn034 · Cited by 79
“lung cancer cell line (Cole et al. 1992) together with”
BackgroundSwerts, K., Moerloose, B. D., Dhooge, C., Laureys, G., Benoît, Y., & Philippé, J. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.017 · Cited by 89
Potent interaction of flavopiridol with MRP1
Hooijberg, J. H., Broxterman, H. J., Scheffer, G. L., Vrasdonk, C., Heijn, M., Jong, M. C. D., Scheper, R. J., Lankelma, J., & Pinedo, H. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690687 · Cited by 79
CFTR, MDR1, and MRP1 Immunolocalization in Normal Human Nasal Respiratory Mucosa
Wioland, M.-A., Fleury–Feith, J., Corlieu, P., Commo, F., Monceaux, G., Lacau-St-Guily, J., & Bernaudin, J.-F. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800905 · Cited by 79
Versantvoort, C. H. M., Bagrij, T., Wright, K. A., & Twentyman, P. R. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630617 · Cited by 90
P-glycoprotein--a marker of cancer-cell behavior.
Pinedo, H., & Giaccone, G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332111 · Cited by 85
Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters
Grube, M., Hagen, P., & Jedlitschky, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00354 · Cited by 92
“As the founding member, MRP1 (ABCC1) was identified as second export pump conferring a multidrug resistance phenotype besides the MDR1/P-glycoprotein (ABCB1) (Cole et al., 1992).”
BackgroundMechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Alatise, K. L., Gardner, S., & Alexander-Bryant, A. A. (2022) · Cancers · doi:10.3390/cancers14246246 · Cited by 97
“The protein was discovered in a multidrug-resistant lung cancer cell line that did not overexpress ABCB1 [27].”
BackgroundKim, S. W., Kim, J. W., Kim, Y. T., Kim, J., Kim, S., Yoon, B. S., Nam, E. J., & Kim, H. Y. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20384 · Cited by 78
“The mechanisms underlying drug resistance are multifactorial and include alterations in oncogene expression and signal transduction pathways (Cole et al., 1992; Gottesman et al., 2002), but little is known about the possible underlying genetic changes in chemoresistant disease.”
BackgroundHu, X., & Xuan, Y. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.11.007 · Cited by 80
Mechanisms of cancer: multidrug resistance
Filipits, M. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.10.001 · Cited by 91
The role of extracellular matrix in small-cell lung cancer
Rintoul, R. C., & Sethi, T. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00421-6 · Cited by 78
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.